Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
This study is to examine which dose of DA-3031(PEG-G-CSF) has similar efficacy and safety compared to daily G-CSF in chemotherapy-induced neutropenia.
Chemotherapy Induced Neutropenia
DRUG: PEG-G-CSF|DRUG: G-CSF
Duration of grade 4 neutropenia in cycle 1, Grade 4 neutropenia means the ANC count is less than 500/mm3., 21 day
ANC nadir in cycle 1, ANC nadir means the lowest point of ANC count., 21 day|Time to ANC recovery in cycle 1, ANC recovery means the ANC count is more than 2,000/mm3., 21 day|Incidence of febrile neutropenia in cycle 1, Febrile neutropenia means the ANC count is less than 1,000/mm3 and body temperature is more than 38.5 degrees celsius., 21 day|Incidence of IV antibiotics administration in cycle 1, IV antibiotics administration means that antibiotics are administered through intravenous route., 21 day
Eligible subjects are randomly assigned to receive once-per-cycle DA-3031(PEG-G-CSF) or daily G-CSF(up to 10 days). This study is conducted for 1 cycles of chemotherapy.